在各种流行病阶段的COVID-19中非严重的肝损伤:现实世界的研究

Jirayuth Winyupakorn1, Chunlanee Sangketchon2, Watcharaporn Devakul Na Ayutthaya3

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, 10300, Thailand.

概括

轻度COVID-19患者经历的肝损伤最小,允许在短期住院期间使用多种药物. 某些抗病毒药物,如法维皮拉维尔和雷梅西维尔,显示肝酶的暂时增加.